The study of Immucyst for the prophylaxis of the superficial bladder cancer at a intermediate risk for the intravesical recurrence

Trial Profile

The study of Immucyst for the prophylaxis of the superficial bladder cancer at a intermediate risk for the intravesical recurrence

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Sep 2015

At a glance

  • Drugs BCG (Primary) ; BCG (Primary)
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Acronyms IMAX
  • Most Recent Events

    • 20 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top